This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
infectious peritonitis | 860 |
feline infectious | 848 |
feline coronavirus | 361 |
clinical signs | 315 |
mg kg | 194 |
infected cats | 171 |
peritonitis virus | 170 |
healthy cats | 151 |
feline enteric | 133 |
spinal cord | 120 |
enteric coronavirus | 118 |
without fip | 115 |
cats without | 108 |
type i | 107 |
lymph nodes | 102 |
feline coronaviruses | 101 |
fip cats | 96 |
type ii | 87 |
tissue samples | 85 |
weight loss | 84 |
coronavirus infection | 80 |
present study | 79 |
foreign bodies | 74 |
one study | 73 |
affected cats | 72 |
antibody titers | 72 |
fcov rna | 71 |
spike protein | 71 |
chain reaction | 69 |
polymerase chain | 69 |
liver disease | 64 |
definitive diagnosis | 64 |
lymph node | 64 |
acid glycoprotein | 63 |
specific antibodies | 62 |
virus infection | 62 |
may also | 61 |
significantly higher | 59 |
blood pressure | 59 |
per cent | 58 |
physical examination | 58 |
gene mutations | 58 |
survival time | 58 |
naturally occurring | 58 |
small intestine | 57 |
mesenteric lymph | 57 |
blood samples | 57 |
may occur | 57 |
nervous system | 56 |
two cats | 55 |
foreign body | 55 |
reverse transcriptase | 53 |
amino acid | 53 |
antibody titres | 52 |
immune response | 52 |
hepatic lipidosis | 52 |
central nervous | 51 |
peripheral blood | 51 |
immunodeficiency virus | 51 |
control group | 50 |
one cat | 50 |
fcov zu | 50 |
small cell | 49 |
effusive fip | 49 |
statistically significant | 48 |
spf cats | 48 |
significant difference | 48 |
fcov antigen | 48 |
median age | 47 |
bowel disease | 47 |
inflammatory bowel | 46 |
viral antigen | 46 |
naturally infected | 46 |
feline immunodeficiency | 45 |
placebo group | 45 |
healthy dogs | 44 |
fcov infection | 44 |
cord uid | 44 |
doc id | 44 |
fcov antibody | 43 |
cell lymphoma | 43 |
control cats | 41 |
ng ml | 41 |
every hours | 41 |
acute phase | 41 |
heart failure | 40 |
fip disease | 39 |
bone marrow | 39 |
effusive form | 39 |
performed using | 38 |
viral rna | 38 |
fip group | 38 |
fecal samples | 38 |
risk factors | 37 |
faecal samples | 37 |
experimentally infected | 37 |
fip lesions | 36 |
three cats | 36 |
retrospective study | 36 |
gastrointestinal tract | 36 |
plasma protein | 35 |
coronavirus antigen | 35 |
veterinary medicine | 35 |
cats may | 35 |
cats infected | 35 |
diabetes mellitus | 34 |
neurological signs | 34 |
gastrointestinal disease | 34 |
fip cases | 33 |
linear foreign | 33 |
positive results | 33 |
monocytes macrophages | 32 |
occurring feline | 32 |
significantly lower | 32 |
tested positive | 32 |
small animal | 32 |
cerebrospinal fluid | 31 |
median survival | 31 |
renal disease | 31 |
fip coronavirus | 31 |
feline leukemia | 31 |
coronavirus infections | 31 |
leukemia virus | 30 |
fcov type | 30 |
immune complexes | 30 |
animal health | 30 |
coronavirus antibody | 30 |
monoclonal antibodies | 30 |
clinical presentation | 29 |
older cats | 29 |
commercially available | 29 |
body weight | 29 |
small intestinal | 29 |
previous studies | 29 |
statistical analysis | 29 |
protein binding | 29 |
biopsy samples | 28 |
plasma cells | 28 |
non fip | 28 |
cell culture | 28 |
adult cats | 28 |
large intestine | 28 |
diagnostic test | 28 |
case series | 28 |
canine coronavirus | 28 |
underlying cause | 28 |
survival factors | 27 |
granulomatous lesions | 27 |
enteric coronaviruses | 27 |
common cause | 27 |
peritonitis feline | 27 |
kg po | 27 |
fip virus | 27 |
viral loads | 27 |
alveolar macrophages | 27 |
mrna expression | 26 |
diagnostic value | 26 |
toxoplasma gondii | 26 |
hepatitis virus | 26 |
transmissible gastroenteritis | 26 |
protein gene | 26 |
complete blood | 26 |
immune system | 26 |
previously described | 26 |
confirmed fip | 26 |
body cavity | 26 |
side effects | 26 |
total protein | 26 |
aqueous humor | 25 |
effusion samples | 25 |
disease may | 25 |
sialic acid | 25 |
fcov antibodies | 25 |
significant differences | 25 |
monoclonal antibody | 25 |
sequence analysis | 25 |
may result | 24 |
endemic feline | 24 |
clinically normal | 24 |
histological lesions | 24 |
reverse transcription | 24 |
mitral valve | 24 |
commonly used | 24 |
cell differentiation | 24 |
coronavirus antibodies | 24 |
serum protein | 24 |
fatal disease | 23 |
blood count | 23 |
many cats | 23 |
body fat | 23 |
pcr assay | 23 |
systemic spread | 23 |
body condition | 23 |
virus infections | 23 |
serum samples | 23 |
five cats | 23 |
serum cobalamin | 23 |
mononuclear cells | 23 |
pcr positive | 23 |
fipv infection | 23 |
one case | 23 |
medical records | 23 |
large bowel | 23 |
necrosis factor | 22 |
cardiac injury | 22 |
less common | 22 |
dp dt | 22 |
experimentally induced | 22 |
valve disease | 22 |
gastrointestinal signs | 22 |
acute pancreatitis | 22 |
eight cats | 22 |
young cats | 22 |
significantly different | 22 |
plasma samples | 22 |
least one | 22 |
baff mrna | 22 |
mean age | 22 |
underlying disease | 22 |
small number | 22 |
royal canin | 22 |
diagnostic tests | 22 |
mg dl | 22 |
congestive heart | 22 |
left ventricular | 22 |
domestic cats | 21 |
clinical diagnosis | 21 |
mixed breed | 21 |
kidney disease | 21 |
serotype ii | 21 |
virus load | 21 |
challenge stock | 21 |
study period | 21 |
develop fip | 21 |
protein electrophoresis | 21 |
exocrine pancreatic | 21 |
mg cat | 21 |
gastroenteritis virus | 21 |
shedding virus | 21 |
accessory genes | 21 |
tumor necrosis | 21 |
phylogenetic analysis | 21 |
heart rate | 21 |
virus shedding | 21 |
dependent enhancement | 21 |
positive cats | 20 |
tritrichomonas foetus | 20 |
reference range | 20 |
lesions consistent | 20 |
ck activity | 20 |
viral replication | 20 |
viral sequences | 20 |
adverse effects | 20 |
pcr assays | 20 |
false positive | 20 |
intestinal obstruction | 20 |
chronic kidney | 20 |
clinically healthy | 20 |
differentiation survival | 20 |
rpad index | 20 |
portosystemic shunts | 20 |
transcriptase polymerase | 20 |
cats treated | 20 |
severe acute | 20 |
infected macrophages | 20 |
abdominal pain | 20 |
among cats | 20 |
antibody titer | 20 |
young dogs | 19 |
pathological findings | 19 |
fcov shedding | 19 |
liver enzymes | 19 |
laboratory tests | 19 |
cellular composition | 19 |
signs may | 19 |
left atrial | 19 |
mouse hepatitis | 19 |
csf mrna | 19 |
cats feline | 19 |
body fluids | 19 |
recent study | 19 |
transcription levels | 19 |
positive cells | 19 |
cat environments | 19 |
kg day | 19 |
feline macrophages | 19 |
logistic regression | 19 |
coronavirus spike | 19 |
determine whether | 19 |
ml kg | 19 |
mast cell | 19 |
mg ml | 19 |
two different | 18 |
coronavirus feline | 18 |
pancreatic insufficiency | 18 |
predictive value | 18 |
lymphatic tissues | 18 |
cattery cats | 18 |
cipf whwts | 18 |
pleural effusion | 18 |
direct immunofluorescence | 18 |
neurologic disease | 18 |
results suggest | 18 |
bcs model | 18 |
high viral | 18 |
four cats | 18 |
supportive care | 18 |
time point | 18 |
many cases | 18 |
normal cats | 18 |
blood cells | 18 |
pcr product | 18 |
cat population | 18 |
disease process | 18 |
phase proteins | 18 |
companion animal | 18 |
culture supernatant | 18 |
neutrophil survival | 18 |
nucleic acid | 18 |
intervertebral disc | 18 |
see table | 17 |
medical management | 17 |
fipv vaccine | 17 |
coronavirus type | 17 |
molecular detection | 17 |
central neurologic | 17 |
antibody titre | 17 |
time rt | 17 |
cats suspected | 17 |
small animals | 17 |
ii feline | 17 |
negative results | 17 |
younger cats | 17 |
liver diseases | 17 |
intestinal disease | 17 |
blood glucose | 17 |
hepatic encephalopathy | 17 |
septic peritonitis | 17 |
cats showed | 17 |
critical assessment | 17 |
previous study | 17 |
two groups | 17 |
infectious diseases | 17 |
pcr products | 17 |
copy numbers | 17 |
cavity effusions | 17 |
long axis | 17 |
bile acids | 17 |
chronic pancreatitis | 17 |
breeding colony | 17 |
serotype i | 17 |
acid changes | 17 |
room temperature | 17 |
cats suffering | 17 |
intestinal wall | 17 |
tissue fecal | 17 |
ascitic fluid | 17 |
crp concentrations | 17 |
brain barrier | 17 |
gastric emptying | 17 |
feline interferon | 16 |
post mortem | 16 |
signs include | 16 |
cats affected | 16 |
diseased tissues | 16 |
feline plasma | 16 |
respiratory syndrome | 16 |
bartonella spp | 16 |
mes lnn | 16 |
fluid therapy | 16 |
poor outcome | 16 |
inflammatory diseases | 16 |
tape measure | 16 |
vaccine group | 16 |
general anesthesia | 16 |
another study | 16 |
isothermal amplification | 16 |
peritonitis among | 16 |
leucine codon | 16 |
may cause | 16 |
bowel diarrhea | 16 |
liver tissue | 16 |
also found | 16 |
creatine kinase | 16 |
computed tomography | 16 |
stock virus | 16 |
inclusion criteria | 16 |
systolic blood | 15 |
peritonitis detection | 15 |
tissue cysts | 15 |
viral load | 15 |
fcov strains | 15 |
negative controls | 15 |
time points | 15 |
diagnose feline | 15 |
fipv strain | 15 |
prospective study | 15 |
types i | 15 |
survival times | 15 |
one dog | 15 |
age years | 15 |
cat populations | 15 |
blood cell | 15 |
systemic hypertension | 15 |
time pcr | 15 |
study showed | 15 |
viruses arise | 15 |
red blood | 15 |
cellular immunity | 15 |
peritonitis viruses | 15 |
clinical findings | 15 |
coronavirus rna | 15 |
phase protein | 15 |
renal failure | 15 |
infected cat | 15 |
highly conserved | 15 |
study found | 15 |
acute respiratory | 15 |
disease outcome | 15 |
experimental infection | 15 |
liver function | 15 |
antibiotic therapy | 15 |
exact test | 15 |
study aimed | 15 |
teaching hospital | 15 |
inflammatory response | 15 |
diabetic cats | 15 |
mediated immune | 15 |
pet cats | 15 |
analyzed using | 15 |
right parasternal | 14 |
ccl concentrations | 14 |
detect fcov | 14 |
related strains | 14 |
short axis | 14 |
fcov mrna | 14 |
positive result | 14 |
within macrophages | 14 |
antigen expression | 14 |
expression levels | 14 |
two related | 14 |
fip pathogenesis | 14 |
control dogs | 14 |
positive predictive | 14 |
differential diagnosis | 14 |
bile duct | 14 |
esophageal sphincter | 14 |
serum crp | 14 |
stopped shedding | 14 |
real time | 14 |
specific pathogen | 14 |
plasma proteins | 14 |
previous bp | 14 |
intestinal tract | 14 |
closely related | 14 |
oxidative stress | 14 |
antibody detection | 14 |
fluid analysis | 14 |
large number | 14 |
globulin ratio | 14 |
pet owners | 14 |
may show | 14 |
clinical disease | 14 |
kit vegf | 14 |
different organs | 14 |
infectious agents | 14 |
low antibody | 14 |
cat households | 14 |
blood vessels | 14 |
serum biochemistry | 14 |
purebreed cats | 14 |
cobalamin supplementation | 14 |
within hours | 14 |
coronavirus isolates | 14 |
important role | 14 |
clinical symptoms | 14 |
mediated isothermal | 14 |
infectious disease | 14 |
needle aspiration | 14 |
abdominal cavity | 14 |
methionine codon | 14 |
several studies | 14 |
laboratory findings | 14 |
lgl lymphoma | 14 |
acute onset | 14 |
abdominal ultrasound | 14 |
older dogs | 14 |
breed dogs | 14 |
low sensitivity | 14 |
respiratory disease | 14 |
human medicine | 14 |
domestic shorthair | 14 |
amino acids | 14 |
dif test | 13 |
purebred cats | 13 |
blood mononuclear | 13 |
clinical suspicion | 13 |
infected animals | 13 |
united states | 13 |
right ventricular | 13 |
changes consistent | 13 |
serosal surfaces | 13 |
immunocompromised cats | 13 |
mortem diagnosis | 13 |
high antibody | 13 |
feline pancreatic | 13 |
agarose gel | 13 |
significant correlation | 13 |
ante mortem | 13 |
protein content | 13 |
serum concentration | 13 |
veterinary teaching | 13 |
liquid chromatography | 13 |
study included | 13 |
cytokine mrna | 13 |
samples obtained | 13 |
clinical sign | 13 |
spinal trauma | 13 |
different breeds | 13 |
corona virus | 13 |
noneffusive fip | 13 |
cats diagnosed | 13 |
pilot study | 13 |
lower esophageal | 13 |
free water | 13 |
case reports | 13 |
peritonitis using | 13 |
virus isolated | 13 |
exposed cats | 13 |
risk factor | 13 |
feline population | 13 |
dogs presented | 13 |
cytokine transcription | 13 |
rv function | 13 |
induced feline | 13 |
see chapter | 13 |
cord dysfunction | 13 |
siamese cats | 13 |
feline serum | 13 |
indirect immunofluorescence | 13 |
endothelial cells | 13 |
tested negative | 13 |
neurological fip | 13 |
condition score | 13 |
cats received | 13 |
cord injury | 13 |
sick cats | 13 |
feline lymphoma | 13 |
pathological fagp | 13 |
histopathologic examination | 13 |
veterinary hospital | 12 |
even though | 12 |
fip affected | 12 |
serum ccl | 12 |
recent studies | 12 |
test results | 12 |
alt levels | 12 |
cell tumors | 12 |
nested pcr | 12 |
whole blood | 12 |
disc disease | 12 |
chronic renal | 12 |
oral cobalamin | 12 |
diagnostic accuracy | 12 |
fusion peptide | 12 |
fat percentage | 12 |
respiratory signs | 12 |
detection mix | 12 |
findings suggest | 12 |
antibody levels | 12 |
fine needle | 12 |
human patients | 12 |
samples tested | 12 |
cleavage site | 12 |
histological examination | 12 |
years old | 12 |
pulmonary arterial | 12 |
transcriptase pcr | 12 |
disease severity | 12 |
thoracic radiographs | 12 |
felv infection | 12 |
diseased cats | 12 |
cats tested | 12 |
relative copy | 12 |
modified live | 12 |
urinary tract | 12 |
min mg | 12 |
biochemistry profile | 12 |
examination findings | 12 |
cell depletion | 12 |
cat may | 12 |
cats naturally | 12 |
fcov rt | 12 |
haemolymphatic tissues | 12 |
small bowel | 12 |
premature stop | 12 |
final diagnosis | 12 |
cd vegf | 12 |
increased risk | 12 |
higher viral | 12 |
amplification products | 12 |
fluid samples | 12 |
nmoles min | 12 |
reference standard | 12 |
virulent fipv | 12 |
inflammatory disease | 12 |
different types | 12 |
intestinal inflammation | 12 |
pcr results | 12 |
cat breeds | 12 |
challenge exposure | 12 |
one hundred | 12 |
portal hypertension | 12 |
aspiration pneumonia | 12 |
north america | 12 |
smooth muscle | 12 |
highly suggestive | 12 |
control groups | 12 |
infected cells | 12 |
noneffusive disease | 12 |
owned dogs | 12 |
spike gene | 12 |
within days | 12 |
mediated immunity | 12 |
kg iv | 12 |
fcov genome | 12 |
mediated disease | 12 |
protein concentration | 12 |
annular hypoplasia | 12 |
immunologic aspects | 12 |
gall bladder | 12 |
positive samples | 12 |
peritonitis date | 12 |
postmortem examination | 12 |
procoagulant activity | 12 |
clinical improvement | 12 |
nasal discharge | 12 |
gene expression | 12 |
coronavirus serology | 12 |
cells positive | 12 |
systolic function | 11 |
inflammatory cells | 11 |
intestinal small | 11 |
needle aspirates | 11 |
positive rt | 11 |
respiratory rate | 11 |
also occur | 11 |
clinical cases | 11 |
skin lesions | 11 |
may lead | 11 |
fip resistance | 11 |
serum concentrations | 11 |
der felinen | 11 |
epithelial cells | 11 |
disease processes | 11 |
bacterial infection | 11 |
dogs treated | 11 |
nine dogs | 11 |
wall thickness | 11 |
cell count | 11 |
body temperature | 11 |
may include | 11 |
helicobacter infection | 11 |
single nucleotide | 11 |
feline liver | 11 |
well tolerated | 11 |
ii fipv | 11 |
virus variants | 11 |
developed fip | 11 |
systemic disease | 11 |
also possible | 11 |
mrna levels | 11 |
also observed | 11 |
affected organs | 11 |
chronic disease | 11 |
mutated fcov | 11 |
renal function | 11 |
cats presenting | 11 |
primary vaccination | 11 |
mutation frequencies | 11 |
resonance imaging | 11 |
histopathological changes | 11 |
commonly associated | 11 |
fip diagnosis | 11 |
using feline | 11 |
differential diagnoses | 11 |
mesothelial cells | 11 |
mortality rate | 11 |
crp concentration | 11 |
described previously | 11 |
fip may | 11 |
csf analysis | 11 |
classical signs | 11 |
red pulp | 11 |
tissue culture | 11 |
felv fiv | 11 |
significantly increased | 11 |
case report | 11 |
another disease | 11 |
may contribute | 11 |
significantly associated | 11 |
elevated liver | 11 |
rna viruses | 11 |
stop codon | 11 |
magnetic resonance | 11 |
cats experimentally | 11 |
survival rate | 11 |
producing coronavirus | 11 |
signs consistent | 11 |
fcov types | 11 |
gastroesophageal reflux | 11 |
high rate | 11 |
gastric acid | 11 |
sinonasal aspergillosis | 11 |
pleural effusions | 11 |
oral administration | 11 |
may present | 11 |
natural infection | 11 |
alkaline phosphatase | 11 |
ck isoenzymes | 11 |
fip symptoms | 11 |
success rate | 11 |
effective treatment | 11 |
canned food | 10 |
mortem examination | 10 |
immune responses | 10 |
isothermal mastermix | 10 |
higher risk | 10 |
consultation room | 10 |
different fcov | 10 |
macrophage tropism | 10 |
obese dogs | 10 |
cat litter | 10 |
two studies | 10 |
abdominal organs | 10 |
high levels | 10 |
positive dogs | 10 |
several days | 10 |
bb activity | 10 |
acid sequence | 10 |
liver biopsy | 10 |
parvoviral enteritis | 10 |
ii strains | 10 |
likelihood ratios | 10 |
animal practice | 10 |
field conditions | 10 |
clinical outcome | 10 |
negative lymph | 10 |
veterinary clinics | 10 |
mmol mol | 10 |
virulent strains | 10 |
globulin concentrations | 10 |
suspected fip | 10 |
cells producing | 10 |
fipv isolates | 10 |
abdominal palpation | 10 |
novel protein | 10 |
fiv infection | 10 |
developing fip | 10 |
may reveal | 10 |
upper respiratory | 10 |
viral genome | 10 |
class ii | 10 |
ill cats | 10 |
lad lab | 10 |
protein concentrations | 10 |
considered significant | 10 |
fip exhibit | 10 |
serologic studies | 10 |
previously reported | 10 |
organ samples | 10 |
cats inoculated | 10 |
virulent fcovs | 10 |
type iv | 10 |
analysis based | 10 |
pip disease | 10 |
mrna responses | 10 |
step rt | 10 |
acvim class | 10 |
surgical correction | 10 |
chronic enteropathies | 10 |
clinicopathological changes | 10 |
negative rt | 10 |
glycosylation pattern | 10 |
six cats | 10 |
diagnostic tool | 10 |
fip vaccine | 10 |
healthy fcov | 10 |
twice daily | 10 |
biopsy specimens | 10 |
cat guardians | 10 |
i feline | 10 |
cytokine responses | 10 |
uc davis | 10 |
potentially consistent | 10 |
tricuspid valve | 10 |
first time | 10 |
naturally fcov | 10 |
mouse monoclonal | 10 |
clinical history | 10 |
organ damage | 10 |
experimental studies | 10 |
viral antigens | 10 |
cardiac disease | 10 |
signs associated | 10 |
pancreatic disease | 10 |
diseased omentum | 10 |
highly virulent | 10 |
diarrhea may | 10 |
cats will | 10 |
cord disease | 10 |
chi square | 10 |
clotrimazole cream | 10 |
negative ihc | 10 |
giardia duodenalis | 10 |
high cd | 10 |
peritoneal macrophages | 10 |
pulmonic stenosis | 10 |
pancreatic lipase | 10 |
information found | 10 |
bred cats | 10 |
positive ihc | 10 |
image quality | 10 |
seven dogs | 10 |
natural fcov | 10 |
seven cats | 10 |
surgical treatment | 10 |
pathologic changes | 10 |
bile acid | 10 |
related cats | 10 |
esophageal disease | 10 |
included cats | 10 |
two cases | 10 |
gold standard | 10 |
less likely | 10 |
heart disease | 10 |
sars coronavirus | 10 |
different biotypes | 10 |
also showed | 10 |
clinicopathological findings | 10 |
assessed using | 10 |
internal medicine | 10 |
biochemistry panel | 10 |
viral spike | 10 |
long term | 10 |
first vaccination | 10 |
breed cats | 10 |
observational study | 9 |
blood ammonia | 9 |
informed consent | 9 |
molecular weight | 9 |
high doses | 9 |
sinus rhythm | 9 |
immunohistochemical staining | 9 |
myeloid histiocyte | 9 |
intrinsic resistance | 9 |
comparative sequence | 9 |
skeletal muscle | 9 |
without feline | 9 |
anterior uveitis | 9 |
coronaviruses feline | 9 |
antigen within | 9 |
feline peritoneal | 9 |
serum creatinine | 9 |
measured using | 9 |
adult dogs | 9 |
cats examined | 9 |
severe disease | 9 |
free wall | 9 |
health status | 9 |
experimental conditions | 9 |
antigen unmasking | 9 |
cryostatic sections | 9 |
hepatic disease | 9 |
cats receiving | 9 |
sequence identity | 9 |
cats using | 9 |
primer pairs | 9 |
intestinal mucosa | 9 |
peg tube | 9 |
abdominal effusion | 9 |
infectious causes | 9 |
genetic determinants | 9 |
ocular lesions | 9 |
report describes | 9 |
may require | 9 |
challenge virus | 9 |
less frequently | 9 |
nutritional support | 9 |
veterinary practice | 9 |
cord diseases | 9 |
ocular signs | 9 |
different time | 9 |
underlying causes | 9 |
bcs diagnosis | 9 |
virus replication | 9 |
histopathologically confirmed | 9 |
bacterial infections | 9 |
presumptive diagnosis | 9 |
fip based | 9 |
cd cd | 9 |
furin cleavage | 9 |
vaccinated cats | 9 |
remains unclear | 9 |
healthy animals | 9 |
mouse brain | 9 |
molecular genetics | 9 |
recombinant feline | 9 |
quantitative real | 9 |
samples collected | 9 |
creatinine ratio | 9 |
concurrent diseases | 9 |
globulin levels | 9 |
diagnostic purposes | 9 |
diagnosing fip | 9 |
cns diseases | 9 |
may help | 9 |
preliminary results | 9 |
radiographs may | 9 |
immunohistochemical findings | 9 |
fecal shedding | 9 |
bacterial overgrowth | 9 |
coronavirus strain | 9 |
glycaemic control | 9 |
two distinct | 9 |
antibody production | 9 |
therapy may | 9 |
inflammation may | 9 |
false negative | 9 |
mrna rt | 9 |
histiocyte antigen | 9 |
cd ligand | 9 |
vivo virulence | 9 |
i fcovs | 9 |
seropositive cats | 9 |
cats undergoing | 9 |
enteric infection | 9 |
cd lymphocytes | 9 |
kg sc | 9 |
dogs affected | 9 |
molecular biology | 9 |
total ck | 9 |
disseminated intravascular | 9 |
zoonotic potential | 9 |
antigenic relationship | 9 |
healthy fecv | 9 |
transit time | 9 |
well known | 9 |
genomic rna | 9 |
anal sac | 9 |
systemic signs | 9 |
serum total | 9 |
chronic gastritis | 9 |
transcription unit | 9 |
hypertensive encephalopathy | 9 |
alanine aminotransferase | 9 |
buffered saline | 9 |
fatty acids | 9 |
high prevalence | 9 |
animal hospital | 9 |
four related | 9 |
cell cultures | 9 |
like immunoreactivity | 9 |
high protein | 9 |
observation period | 9 |
antibody tests | 9 |
heart size | 9 |
remained negative | 9 |
family coronaviridae | 9 |
stimulating factor | 9 |
feline agp | 9 |
diagnosis may | 9 |
pulmonary artery | 9 |
white blood | 9 |
diseases associated | 9 |
feline calicivirus | 9 |
shedding fcov | 9 |
leukaemia virus | 8 |
decreased albumin | 8 |
distemper virus | 8 |
master mix | 8 |
lipase immunoreactivity | 8 |
feline pancreatitis | 8 |
remaining cats | 8 |
higher incidence | 8 |
right ventricle | 8 |
cardiac size | 8 |
faecal fcov | 8 |
clinical feline | 8 |
domestic cat | 8 |
dogs underwent | 8 |
clinical practice | 8 |
housekeeping gene | 8 |
highly digestible | 8 |
live fipv | 8 |
serum bile | 8 |
acute necrotizing | 8 |
intravascular coagulation | 8 |
tissue distribution | 8 |
recent paper | 8 |
whwts respectively | 8 |
respiratory coronavirus | 8 |
blood monocytes | 8 |
virus within | 8 |
systemic infection | 8 |
pressure measurements | 8 |
shelter cats | 8 |
needle biopsy | 8 |
cardiovascular disease | 8 |
future studies | 8 |
right pulmonary | 8 |
available kit | 8 |
vitro studies | 8 |
include vomiting | 8 |
cobalamin concentrations | 8 |
cats presented | 8 |
cell entry | 8 |
lymphocytic neoplasia | 8 |
precise diagnosis | 8 |
small amounts | 8 |
reactive protein | 8 |
fecal virus | 8 |
mediated vasculitis | 8 |
different tests | 8 |
primary antibody | 8 |
persistently infected | 8 |
every cat | 8 |
lung function | 8 |
gastric ulceration | 8 |
without significant | 8 |
ifa positive | 8 |
may allow | 8 |
diagnose fip | 8 |
different groups | 8 |
current study | 8 |
fcov infected | 8 |
mhc class | 8 |
mucous membranes | 8 |
three dogs | 8 |
protein fusion | 8 |
healthy adult | 8 |
dendritic cells | 8 |
likely due | 8 |
four days | 8 |
zu strain | 8 |
feline aminopeptidase | 8 |
standard deviation | 8 |
purebred catteries | 8 |
nucleotide polymorphisms | 8 |
cholangitis syndrome | 8 |
clinical course | 8 |
virus type | 8 |
staphylococcus spp | 8 |
boehringer ingelheim | 8 |
glycan moiety | 8 |
immune complex | 8 |
dilated cardiomyopathy | 8 |
neurologic fip | 8 |
may develop | 8 |
feline ascites | 8 |
often present | 8 |
sequences encoding | 8 |
laboratory parameters | 8 |
viral diseases | 8 |
ng cm | 8 |
often occurs | 8 |
live virus | 8 |
low intensity | 8 |
commonly reported | 8 |
negative predictive | 8 |
common clinical | 8 |
three groups | 8 |
groups using | 8 |
successful treatment | 8 |
virus vaccine | 8 |
using direct | 8 |
rna detection | 8 |
feline panleukopenia | 8 |
suspected feline | 8 |
carrier cats | 8 |
affected dogs | 8 |
renal mineralization | 8 |
central necrosis | 8 |
vector laboratories | 8 |
sick dogs | 8 |
gondii infection | 8 |
feline leukaemia | 8 |
results indicate | 8 |
rank test | 8 |
pressure measurement | 8 |
virus antigen | 8 |
herpes virus | 8 |
nucleotide sequence | 8 |
discrete foreign | 8 |
vice versa | 8 |
gi disease | 8 |
abdominal fluid | 8 |
phylogenetic trees | 8 |
within weeks | 8 |
hagp antibody | 8 |
pcr detecting | 8 |
year period | 8 |
embedded tissues | 8 |
clinical examination | 8 |
two types | 8 |
prepatent period | 8 |
lateral recumbency | 8 |
immunohistochemically confirmed | 8 |
homologous recombination | 8 |
predictive values | 8 |
one sample | 8 |
also present | 8 |
neurological dysfunction | 8 |
different diagnostic | 8 |
gallbladder agenesis | 8 |
cats showing | 8 |
dogs showed | 8 |
disease course | 8 |
feline alveolar | 8 |
type iii | 8 |
findings may | 8 |
university veterinary | 8 |
odds ratio | 8 |
leishmania spp | 8 |
growth factor | 8 |
veterinary medical | 8 |
host factors | 8 |
hrct ga | 8 |
stricture formation | 8 |
tac levels | 8 |
field strains | 8 |
retrospectively reviewed | 8 |
murine hepatitis | 8 |
cell tumor | 8 |
adjunctive therapy | 8 |
tissues using | 8 |
serum antibodies | 8 |
fip incidence | 8 |
may play | 8 |
dogs diagnosed | 8 |
neurologic feline | 8 |
immunofluorescence test | 8 |
three different | 8 |
severe clinical | 8 |
purified fagp | 8 |
abc genes | 8 |
cats younger | 8 |
diastolic rv | 8 |
treg cells | 8 |
biliary tree | 8 |
fip among | 8 |
oral route | 8 |
study population | 8 |
double recombination | 8 |
chronic mitral | 8 |
acid change | 8 |
gastrointestinal lymphoma | 8 |
positive correlation | 8 |
accessory proteins | 8 |
labrador retrievers | 8 |
sample material | 8 |
cats develop | 8 |
days later | 8 |
cats compared | 8 |
false positives | 8 |
author prefers | 8 |
antibody testing | 8 |
reading frame | 8 |
systemic diseases | 8 |
pcr testing | 8 |
immunosorbent assay | 8 |
baos dogs | 8 |
colonic mucosa | 8 |
intestinal epithelium | 8 |
coronavirus virulence | 8 |
structural proteins | 8 |
samples positive | 8 |
less commonly | 8 |
peritoneal cavity | 8 |
despite absence | 8 |
vascular lesions | 8 |
fresh organ | 7 |
orf abc | 7 |
veterinary science | 7 |
cat owners | 7 |
rna isolation | 7 |
anaplasma phagocytophilum | 7 |
diagnostic laboratories | 7 |
fipv replication | 7 |
cytokine production | 7 |
complete remission | 7 |
antimicrobial resistance | 7 |
fecal incontinence | 7 |
ii positive | 7 |
field strain | 7 |
gross lesions | 7 |
geriatric cats | 7 |
certain breeds | 7 |
increased concentrations | 7 |
results obtained | 7 |
definitively diagnosed | 7 |
within minutes | 7 |
diagnostic testing | 7 |
heart murmur | 7 |
animal model | 7 |
clinical pathology | 7 |
target organ | 7 |
congenital portosystemic | 7 |
cord compression | 7 |
necrotizing pancreatitis | 7 |
first study | 7 |
regenerative anemia | 7 |
lg kg | 7 |
igg response | 7 |
agp may | 7 |
eight dogs | 7 |
thank dr | 7 |
molecular analysis | 7 |
median years | 7 |
common bile | 7 |
sialyl lewis | 7 |
primers fecv | 7 |
cat feline | 7 |
day course | 7 |
feline kidney | 7 |
without extended | 7 |
southern germany | 7 |
wall thickening | 7 |
linked immunosorbent | 7 |
pyogranulomatous lesions | 7 |
may provide | 7 |
cns signs | 7 |
become infected | 7 |
clinical setting | 7 |
genetic susceptibility | 7 |
spinal lymphoma | 7 |
ii fcov | 7 |
pale mucous | 7 |
experimental feline | 7 |
grade lymphoma | 7 |
common causes | 7 |
esophageal stricture | 7 |
infection correlates | 7 |
systemic vascular | 7 |
one third | 7 |
viral gene | 7 |
pancreatic inflammation | 7 |
fcov nucleic | 7 |
phosphate buffer | 7 |
serum biochemical | 7 |
gene sequencing | 7 |
bile ducts | 7 |
multicat households | 7 |
virulent fcov | 7 |
inflammatory cytokines | 7 |
individual cat | 7 |
strand rna | 7 |
particular attention | 7 |
pathological conditions | 7 |
antimicrobial susceptibility | 7 |
specific immune | 7 |
bp pcr | 7 |
endothelial cell | 7 |
soft tissue | 7 |
feline gastrointestinal | 7 |
regression analysis | 7 |
routine laboratory | 7 |
probably due | 7 |
giardia spp | 7 |
inflammatory processes | 7 |
tissue sections | 7 |
companion animals | 7 |
respiratory compromise | 7 |
pcr result | 7 |
study design | 7 |
glucose monitoring | 7 |
orally every | 7 |
pda occlusion | 7 |
study group | 7 |
wide association | 7 |
also may | 7 |
also received | 7 |
distilled water | 7 |
escherichia coli | 7 |
white matter | 7 |
cat without | 7 |
also exhibited | 7 |
ultrasonographic findings | 7 |
fungal plaques | 7 |
clinical chemistry | 7 |
maine coon | 7 |
concurrent disease | 7 |
feline cholangitis | 7 |
state university | 7 |
surgical resection | 7 |
nine cats | 7 |
canine parvovirus | 7 |
low virulence | 7 |
igm titers | 7 |
polyclonal gammopathy | 7 |
young pet | 7 |
skin nodules | 7 |
chronic inflammatory | 7 |
hepatobiliary disease | 7 |
peritonitis coronavirus | 7 |
cats include | 7 |
dry form | 7 |
deep pain | 7 |
term prognosis | 7 |
viral disease | 7 |
cause fip | 7 |
genetic analysis | 7 |
intestinal lymphoma | 7 |
first described | 7 |
persian cats | 7 |
contrast radiography | 7 |
seven days | 7 |
hiatal hernia | 7 |
diagnostic approach | 7 |
spinal fractures | 7 |
lone af | 7 |
rna extraction | 7 |
specific gravity | 7 |
ae sd | 7 |
ii fcovs | 7 |
growth medium | 7 |
obtained using | 7 |
feeding tube | 7 |
cats older | 7 |
five dogs | 7 |
nonspecific signs | 7 |
polyclonal antibody | 7 |
vascular endothelial | 7 |
pulmonary hypertension | 7 |
fiv status | 7 |
troponin i | 7 |
dogs without | 7 |
spinal locomotion | 7 |
infect humans | 7 |
teaching hospitals | 7 |
pressure liquid | 7 |
syndrome coronavirus | 7 |
axis view | 7 |
fecal sample | 7 |
small groups | 7 |
start codon | 7 |
virus isolates | 7 |
urea nitrogen | 7 |
medical teaching | 7 |
foetus infection | 7 |
consensus sequence | 7 |
negative control | 7 |
infection may | 7 |
systolic strain | 7 |
strain fcov | 7 |
gastrointestinal parasites | 7 |
neurologic signs | 7 |
infected monocytes | 7 |
guided fine | 7 |
received financial | 7 |
increased serum | 7 |
significantly greater | 7 |
ammonia levels | 7 |
scoring system | 7 |
using rt | 7 |
cats also | 7 |
determined using | 7 |
pelvic limbs | 7 |
fna samples | 7 |
clinical features | 7 |
vivo mutation | 7 |
statistical analyses | 7 |
buffered solution | 7 |
clinical remission | 7 |
consensus statement | 7 |
noneffusive forms | 7 |
tissue damage | 7 |
confidence interval | 7 |
open reading | 7 |
reference intervals | 7 |
inflammatory liver | 7 |
portal vein | 7 |
pcr detection | 7 |
loads despite | 7 |
cutaneous lesions | 7 |
cardiac diseases | 7 |
one report | 7 |
animal welfare | 7 |
increased significantly | 7 |
i strains | 7 |
coronavirus correlate | 7 |
strong intensity | 7 |
pancreatic cysts | 7 |
shortening fraction | 7 |
widely used | 7 |
serum alpha | 7 |
correlation coefficient | 7 |
respiratory tract | 7 |
rabbit anti | 7 |
target cells | 7 |
kg orally | 7 |
affected animals | 7 |
surgical intervention | 7 |
diagnostic utility | 7 |
cell tropism | 7 |
tube feeding | 7 |
evaluated using | 7 |
cardiac tissue | 7 |
study reported | 7 |
nucleotide sequences | 7 |
tell us | 7 |
presenting signs | 7 |
putative fusion | 7 |
specific cat | 7 |
reference interval | 7 |
multiple comparisons | 7 |
limited value | 7 |
consensus sequences | 7 |
hydrostatic pressure | 7 |
mucosal bacteria | 7 |
may increase | 7 |
positive cases | 7 |
complement activity | 7 |
least weeks | 7 |
electrolyte abnormalities | 7 |
fecal flotation | 7 |
total proteins | 7 |
significant reduction | 7 |
balloon valvuloplasty | 7 |
cavity effusion | 7 |
immunologic phenomena | 7 |
pcr test | 7 |
wet form | 7 |
intranasal inoculation | 7 |
right lateral | 7 |
effusive disease | 7 |
cardiac failure | 7 |
intestinal neoplasia | 7 |
kg dose | 7 |
high pressure | 7 |
tissue macrophages | 7 |
glucose concentrations | 7 |
histopathological examination | 7 |
candidate genes | 7 |
less effective | 7 |
survey radiographs | 7 |
tests performed | 7 |
ventricular hypertrophy | 7 |
tick paralysis | 7 |
immune cells | 7 |
chronic vomiting | 7 |
diagnostic laboratory | 6 |
feline gapdh | 6 |
without effusion | 6 |
consultancy work | 6 |
rna polymerase | 6 |
healthy iwhs | 6 |
normal heart | 6 |
infected healthy | 6 |
cats evaluated | 6 |
information regarding | 6 |
medical therapy | 6 |
pcr amplification | 6 |
vet immunol | 6 |
cases included | 6 |
stock viruses | 6 |
intestinal bacterial | 6 |
echocardiographic variables | 6 |
standard echocardiography | 6 |
corticosteroid therapy | 6 |
done using | 6 |
fip development | 6 |
renal transplantation | 6 |
severely affected | 6 |
clinical samples | 6 |
thickened intestines | 6 |
portosystemic shunting | 6 |
thirteen cats | 6 |
leukocyte counts | 6 |
previously published | 6 |
csf transcription | 6 |
inflammatory process | 6 |
bronchoalveolar lavage | 6 |
sphincter tone | 6 |
noneffusive form | 6 |
may suggest | 6 |
randomly selected | 6 |
liver failure | 6 |
high risk | 6 |
mm hg | 6 |
experimental spinal | 6 |
left shift | 6 |
highly variable | 6 |
coronavirus persistence | 6 |
reproductive status | 6 |
serum agp | 6 |
upper airway | 6 |
disease caused | 6 |
cns disorders | 6 |
clinical diagnoses | 6 |
relative density | 6 |
fatal fip | 6 |
essentially absent | 6 |
previously validated | 6 |
pg ml | 6 |
total number | 6 |
white terriers | 6 |
quantitative reverse | 6 |
primers targeted | 6 |
taiwan university | 6 |
outcome group | 6 |
pacing lead | 6 |
nucleated cells | 6 |
shepherd dogs | 6 |
creative commons | 6 |
different tissues | 6 |
nml sbp | 6 |
data analysis | 6 |
every days | 6 |
po every | 6 |
without neurological | 6 |
ocular discharge | 6 |
supportive therapy | 6 |
cytotoxic drugs | 6 |
minimum database | 6 |
cats used | 6 |
laboklin gmbh | 6 |
mucosal microbiota | 6 |
clinical forms | 6 |
cd expression | 6 |
splenic red | 6 |
typical fip | 6 |
adhesion molecules | 6 |
peritoneal fluid | 6 |
cell population | 6 |
virulent strain | 6 |
negative cats | 6 |
palpation site | 6 |
inflammatory conditions | 6 |
fractional area | 6 |
surgical removal | 6 |
genetic diversity | 6 |
granulomatous vasculitis | 6 |
activity fluctuations | 6 |
assess whether | 6 |
albumin globulin | 6 |
pet samples | 6 |
dog breeds | 6 |
virulent virus | 6 |
liver involvement | 6 |
squamous cell | 6 |
factors may | 6 |
peritonitis pathogenesis | 6 |
arj laa | 6 |
necrotic foci | 6 |
see main | 6 |
deleterious mutations | 6 |
diagnostic imaging | 6 |
pathogen free | 6 |
clinically suspected | 6 |
important disorders | 6 |
negative result | 6 |
advisory board | 6 |
untranslated region | 6 |
sodium succinate | 6 |
peritonitis two | 6 |
antigen test | 6 |
chronic respiratory | 6 |
cats survived | 6 |
cell zones | 6 |
occurring hypoadrenocorticism | 6 |
fcov infections | 6 |
examination revealed | 6 |
quantitative pcr | 6 |
cats seen | 6 |
primer mix | 6 |
current veterinary | 6 |
cell carcinoma | 6 |
cells may | 6 |
positive lymph | 6 |
also reported | 6 |
cryptosporidium spp | 6 |
dose reduction | 6 |
including cats | 6 |
regurgitant jet | 6 |
normal lipase | 6 |
clinical procedure | 6 |
gastritis may | 6 |
stage iii | 6 |
may become | 6 |
deletion mutant | 6 |
treatment options | 6 |
precipitated exudate | 6 |
anaplasma spp | 6 |
iris class | 6 |
pyrosequencing assay | 6 |
genetic drift | 6 |
cat will | 6 |
much less | 6 |
fecal bulk | 6 |
feline medicine | 6 |
mu kg | 6 |
mosaic pattern | 6 |
intestinal foreign | 6 |
acute spinal | 6 |
severe diarrhea | 6 |
main reference | 6 |
vitam diagnosis | 6 |
sbp mmhg | 6 |
structural genes | 6 |
exhibit significantly | 6 |
leishmania infantum | 6 |
may indicate | 6 |
complete physical | 6 |
equally distributed | 6 |
viral pathogenesis | 6 |
studies evaluating | 6 |
lymphocyte subpopulations | 6 |
valve type | 6 |
healthy infected | 6 |
good outcome | 6 |
drug interactions | 6 |
potential causes | 6 |
pedigree cats | 6 |
converting enzyme | 6 |
rt dtee | 6 |
oral supplementation | 6 |
pancytopenic dogs | 6 |
will require | 6 |
mediated diseases | 6 |
made using | 6 |
lumbar vertebra | 6 |
small numbers | 6 |
hours following | 6 |
conserved regions | 6 |
gmbh co | 6 |
mast cells | 6 |
treatment success | 6 |
myxomatous mitral | 6 |
group included | 6 |
reaction mixture | 6 |
fipv ucd | 6 |
left atrium | 6 |
ejection fraction | 6 |
genetic component | 6 |
buffered formalin | 6 |
control period | 6 |
authors declare | 6 |
virus titer | 6 |
serum tt | 6 |
mean ae | 6 |
national taiwan | 6 |
coronavirus genome | 6 |
fcov isolates | 6 |
alpha mrna | 6 |
fecv infection | 6 |
coronavirus pathobiogenesis | 6 |
imaging findings | 6 |
dna polymerase | 6 |
negative dogs | 6 |
arterial hypertension | 6 |
fcov positive | 6 |
fecal material | 6 |
intrahepatic cholestasis | 6 |
drug therapy | 6 |
rna sequence | 6 |
veterinary diagnostic | 6 |
gastrointestinal foreign | 6 |
kindly provided | 6 |
cell surface | 6 |
serum albumin | 6 |
right atrium | 6 |
intracellular organisms | 6 |
giardia infection | 6 |
better understanding | 6 |
granulomas without | 6 |
body position | 6 |
canine leishmaniosis | 6 |
quantitatively analyzed | 6 |
identify intracellular | 6 |
caloric intake | 6 |
local inflammatory | 6 |
adult worms | 6 |
virus strain | 6 |
immunopathol doi | 6 |
ibd dogs | 6 |
individual cats | 6 |
main clinical | 6 |
per sites | 6 |
membrane protein | 6 |
canine pancytopenia | 6 |
sternal recumbency | 6 |
coronavirus mutants | 6 |
cats usually | 6 |
associated factors | 6 |
fipv ku | 6 |
neurologic disorders | 6 |
murine coronavirus | 6 |
oral prednisolone | 6 |
blood sample | 6 |
immunosuppressive therapy | 6 |
higher prevalence | 6 |
rnase free | 6 |
acid secretion | 6 |
mm hcm | 6 |
fip corona | 6 |
standard tape | 6 |
showed higher | 6 |
important step | 6 |
mild ph | 6 |
diagnostic features | 6 |
various organs | 6 |
brachycephalic dogs | 6 |
vascular permeability | 6 |
wide significance | 6 |
diagnostic specificity | 6 |
fcov qrt | 6 |
cell hyperplasia | 6 |
good agreement | 6 |
exclude fip | 6 |
function parameters | 6 |
immunol immunopathol | 6 |
canine coronaviruses | 6 |
liver dysfunction | 6 |
dogs respectively | 6 |
body ingestion | 6 |
many studies | 6 |
protein creatinine | 6 |
sequence carries | 6 |
motor neuron | 6 |
pregnant queens | 6 |
ae months | 6 |
outdoor access | 6 |
cardiac troponin | 6 |
mouse anti | 6 |
diffuse alterations | 6 |
reported cases | 6 |
echocardiographic parameter | 6 |
abnormalities may | 6 |
using mutian | 6 |
healthy carrier | 6 |
presenting complaints | 6 |
area change | 6 |
cats dying | 6 |
culture supernatants | 6 |
replicate within | 6 |
changes may | 6 |
shed virus | 6 |
fatal outcome | 6 |
also important | 6 |
endogenous peroxidase | 6 |
panleukopenia virus | 6 |
rna loads | 6 |
mini kit | 6 |
bootstrap phylogenetic | 6 |
increased numbers | 6 |
intracavitary effusions | 6 |
differ significantly | 6 |
litter box | 6 |
cell activation | 6 |
large numbers | 6 |
fcov spike | 6 |
blood parameters | 6 |
birman cats | 6 |
neoplastic cells | 6 |
pathological changes | 6 |
may reflect | 6 |
doppler echocardiography | 6 |
allopurinol treatment | 6 |
positive pcr | 6 |
wet mount | 6 |
polyclonal anti | 6 |
time reverse | 6 |
total serum | 6 |
laboratory changes | 6 |
results show | 6 |
positively correlated | 6 |
intratumoral foxp | 6 |
strongyloides spp | 6 |
hypocobalaminemic cats | 6 |
iv hypersensitivity | 6 |
cobalamin concentration | 6 |
fecv strains | 6 |
also seen | 6 |
highland white | 6 |
confirm fip | 6 |
owned cats | 6 |
remained significant | 6 |
hypersensitivity reactions | 6 |
french pet | 6 |
provided evidence | 6 |
replicating virus | 6 |
confirmed cases | 6 |
ten cats | 6 |
total bacteria | 6 |
group consisted | 6 |
closed cat | 6 |
necrotizing vasculitis | 6 |
per day | 6 |
disease groups | 6 |
microscopic examination | 6 |
anemia may | 6 |
west highland | 6 |
gastric disease | 6 |
among feline | 6 |
ng objet | 6 |
positive control | 6 |
serum antibody | 6 |
limited information | 6 |
lavage fluid | 6 |
protein bound | 6 |
anal sacs | 6 |
imaging modality | 6 |
liver pathology | 6 |
longer duration | 6 |
staphylococcus aureus | 6 |
referring veterinarians | 6 |
pancreatic duct | 6 |
conserved region | 6 |
vascular anomalies | 6 |
inspiratory phase | 6 |
specific signs | 6 |
foxp treg | 6 |
still remains | 6 |
increased levels | 6 |
cardiac output | 6 |
clinical response | 6 |
kidney cells | 6 |
cats living | 6 |
cell death | 6 |
approximately per | 6 |
methylprednisolone sodium | 6 |
mean hr | 6 |
performed according | 6 |
mann whitney | 6 |
receptor antagonist | 6 |
respiratory distress | 6 |
laboratory cats | 6 |
ehrlichia anaplasma | 6 |
various tissues | 6 |
histopathological findings | 6 |
common feline | 6 |
spf cat | 6 |
cats co | 6 |
time period | 6 |
survival factor | 6 |
gene gapdh | 6 |
shorter os | 6 |
eosinophilic bronchopneumopathy | 6 |
inoculated larvae | 6 |
effects reported | 6 |
immunofluorescent antibody | 6 |
normal cardiac | 6 |
secondary follicles | 6 |
protein cleavage | 6 |
clinical significance | 6 |
acid residues | 6 |
neutralizing antibody | 6 |
abdominal mass | 6 |
supplementary table | 6 |
mean number | 6 |
histopathologic lesions | 6 |
differences per | 6 |
beagle dogs | 6 |
infect cats | 6 |
epidemiology based | 6 |
useful diagnostic | 6 |
study demonstrated | 6 |
daily oral | 6 |
histologic examination | 6 |
sample size | 6 |
reaction mixtures | 6 |
extended necrosis | 6 |
two methods | 6 |
peak velocity | 6 |
allowed identification | 5 |
red dot | 5 |
eleven cats | 5 |
interventricular septum | 5 |
interstitial glucose | 5 |
lesions potentially | 5 |
gene sequences | 5 |
histopathological diagnosis | 5 |
cohort study | 5 |
i fcov | 5 |
electrophoretic pattern | 5 |
retinal detachment | 5 |
pneumonic form | 5 |
fip phenotype | 5 |
felinen infektiosen | 5 |
specific antibody | 5 |
groups according | 5 |
color doppler | 5 |
effusive feline | 5 |
bile peritonitis | 5 |
shorthair cat | 5 |
hypertrophic cardiomyopathy | 5 |
conservative management | 5 |
stained positive | 5 |
probnp concentration | 5 |
diagnostic methods | 5 |
become infective | 5 |
healthy pedigree | 5 |
hepatic failure | 5 |
human coronavirus | 5 |
cats become | 5 |
relatively small | 5 |
common form | 5 |
absolutely diagnostic | 5 |
intact cats | 5 |
test result | 5 |
current knowledge | 5 |
viral infections | 5 |
immunofluorescence staining | 5 |
wallis test | 5 |
neospora caninum | 5 |
experimental inoculation | 5 |
second international | 5 |
applied biosystems | 5 |
vaccine virus | 5 |
tricuspid insufficiency | 5 |
primers used | 5 |
considered positive | 5 |
end point | 5 |
months post | 5 |
gene mutation | 5 |
coronavirus associated | 5 |
still unknown | 5 |
immune mediated | 5 |
attempted immunization | 5 |
early diagnosis | 5 |
bayer animal | 5 |
plasma biochemistry | 5 |
fcov serotype | 5 |
tge virus | 5 |
transmission disequilibrium | 5 |
will help | 5 |
varies greatly | 5 |
obese cats | 5 |
cause clinical | 5 |
antiemetic effect | 5 |
active disease | 5 |
higher mutation | 5 |
significantly decreased | 5 |
shorthair cats | 5 |
lung sounds | 5 |
right limb | 5 |
gej abnormalities | 5 |
natural type | 5 |
fagp polyclonal | 5 |
additional diagnostic | 5 |
falciparum malaria | 5 |
chop induction | 5 |
viral infection | 5 |
veterinary therapy | 5 |
activated macrophages | 5 |
fipv arises | 5 |
also useful | 5 |
wash hands | 5 |
modified transudates | 5 |
ollulanus tricuspis | 5 |
human serum | 5 |
lower airway | 5 |
mutation theory | 5 |
dogs remain | 5 |
study suggest | 5 |
currently available | 5 |
anal gland | 5 |
clinical use | 5 |
cell types | 5 |
age groups | 5 |
clinical specimens | 5 |
asymptomatic cats | 5 |
cell antigens | 5 |
also funded | 5 |
choroid plexus | 5 |
mm tris | 5 |
pancreatic adenocarcinoma | 5 |
human immunodeficiency | 5 |
bacterial culture | 5 |
financial remuneration | 5 |
linear regression | 5 |
antibody responses | 5 |
systemic inflammatory | 5 |
fpli concentrations | 5 |
initial infection | 5 |
murine monoclonal | 5 |
life technologies | 5 |
clinical relevance | 5 |
sequences identified | 5 |
international feline | 5 |
since fcov | 5 |
increased protein | 5 |
surgical management | 5 |
activated mesothelial | 5 |
sensitive fipv | 5 |
fipv pathotype | 5 |
acute forms | 5 |
vaccinated kittens | 5 |
reference strain | 5 |
two fcov | 5 |
body cavities | 5 |
partial base | 5 |
less virulent | 5 |
genetic background | 5 |
kg sid | 5 |
major cross | 5 |
group compared | 5 |
three cases | 5 |
amersham biosciences | 5 |
veterinary internal | 5 |
detected using | 5 |
results must | 5 |
statistical evaluation | 5 |
certain clinical | 5 |
recombination events | 5 |
cats exposed | 5 |
ratios approach | 5 |
test may | 5 |
false negatives | 5 |
factor production | 5 |
common method | 5 |
gender distribution | 5 |
starting dose | 5 |
edta blood | 5 |
acetic acid | 5 |
blood may | 5 |
ethics committee | 5 |
paraspinal hyperesthesia | 5 |
image analysis | 5 |
canine distemper | 5 |
six dogs | 5 |
popliteal lymph | 5 |
annular plane | 5 |
well understood | 5 |
united kingdom | 5 |
feline blood | 5 |
cd antigen | 5 |
macrophages inoculated | 5 |
considered diagnostic | 5 |
anaplasma platys | 5 |
antihypertensive treatment | 5 |
whether serum | 5 |
detect feline | 5 |
per year | 5 |
disease manifestation | 5 |
outflow obstruction | 5 |
tissue doppler | 5 |
infection studies | 5 |
urine bile | 5 |
urine samples | 5 |
group died | 5 |
hair coat | 5 |
two major | 5 |
fipv negative | 5 |
western blotting | 5 |
condition scoring | 5 |
cellular foci | 5 |
many species | 5 |
molecular tests | 5 |
reduce fecal | 5 |
severity scoring | 5 |
extraperitoneal lesions | 5 |
abcd guidelines | 5 |
three new | 5 |
increased prevalence | 5 |
factors act | 5 |
canine mammary | 5 |
clinical score | 5 |
contaminated food | 5 |
cat liver | 5 |
pericardial effusion | 5 |
high sensitivity | 5 |
chronic gastrointestinal | 5 |
purulent inflammations | 5 |
compared using | 5 |
physical exercise | 5 |
disequilibrium test | 5 |
stroke volume | 5 |
time ranging | 5 |
cryptosporidium felis | 5 |
feeding tubes | 5 |
adverse reactions | 5 |
peritonitis experimental | 5 |
using spss | 5 |
signs included | 5 |
stop codons | 5 |
canine chf | 5 |
part i | 5 |
palpable abdominal | 5 |
airway obstruction | 5 |
peritonitis symposium | 5 |
granulomatous inflammation | 5 |
findings associated | 5 |
statistically different | 5 |
foetus trophozoites | 5 |
sinus histiocytes | 5 |
high virus | 5 |
humoral immunity | 5 |
neutrophil apoptosis | 5 |
biotin complex | 5 |
two samples | 5 |
veterinary literature | 5 |
plasma cell | 5 |
meals per | 5 |
quality control | 5 |
pain perception | 5 |
frontal sinus | 5 |
complete response | 5 |
predisposing factors | 5 |
inflammatory infiltrates | 5 |
readily available | 5 |
isospora spp | 5 |
coomassie blue | 5 |
diseases causing | 5 |
histologically confirmed | 5 |
presenting clinical | 5 |
chronic inflammation | 5 |
reported previously | 5 |
lymphocytic plasmacytic | 5 |
sequencing approach | 5 |
diagnostic sensitivity | 5 |
square test | 5 |
form may | 5 |
infection feline | 5 |
veterinary clinic | 5 |
chronic diarrhea | 5 |
rna samples | 5 |
modified transudate | 5 |
occurring chronic | 5 |
specific treatment | 5 |
muscularis layer | 5 |
fluid sample | 5 |
cats shedding | 5 |
minor cross | 5 |
cardiac muscle | 5 |
animal medicine | 5 |
great pyrenees | 5 |
blood flow | 5 |
common presenting | 5 |
weight management | 5 |
filtration rate | 5 |
medical treatment | 5 |
proton pump | 5 |
infektiosen peritonitis | 5 |
lg ml | 5 |
haemoplasma species | 5 |
zu tissue | 5 |
first diagnostic | 5 |
widely accepted | 5 |
lamp assays | 5 |
paper found | 5 |
flow cytometry | 5 |
various feline | 5 |
haemoplasma infection | 5 |
lung disease | 5 |
esophageal strictures | 5 |
plane systolic | 5 |
domestic animals | 5 |
radiation therapy | 5 |
rarely reported | 5 |
normal dogs | 5 |
liver enzyme | 5 |
cervical esophagus | 5 |
also detectable | 5 |
infected mice | 5 |
often used | 5 |
exudate containing | 5 |
high degree | 5 |
two control | 5 |
strongly correlated | 5 |
almost perfect | 5 |
study provides | 5 |
canine renal | 5 |
low virulent | 5 |
i strain | 5 |
glomerular filtration | 5 |
called feline | 5 |
similar clinical | 5 |
ht receptors | 5 |
first report | 5 |
wilcoxon signed | 5 |
laboratory testing | 5 |
etiologic agent | 5 |
feline infections | 5 |
genetic differences | 5 |
spread systemically | 5 |
findings indicate | 5 |
serum feline | 5 |
clinical toxoplasmosis | 5 |
additional information | 5 |
subacute forms | 5 |
expression level | 5 |
times higher | 5 |
investigate whether | 5 |
labrador retriever | 5 |
ventricular septal | 5 |
urinary bladder | 5 |
data suggest | 5 |
tricuspid annular | 5 |
antemortem diagnosis | 5 |
congenital heart | 5 |
acute lesions | 5 |
bite wounds | 5 |
care must | 5 |
peroxidase complex | 5 |
signaling pathways | 5 |
cellular immune | 5 |
clinical parameters | 5 |
important cause | 5 |
intravenous pimobendan | 5 |
complement fractions | 5 |
losing enteropathy | 5 |
terminal stages | 5 |
cats included | 5 |
different diseases | 5 |
biopsy techniques | 5 |
overall prevalence | 5 |
feline pancreas | 5 |
coronavirus mutations | 5 |
paratenic hosts | 5 |
electrophoretic separation | 5 |
scattered throughout | 5 |
strains fipv | 5 |
spinal canal | 5 |
study also | 5 |
tracheobronchial foreign | 5 |
canine population | 5 |
ade macrophages | 5 |
copy number | 5 |
causes include | 5 |
structural protein | 5 |
parietal cells | 5 |
already reported | 5 |
cats evaluation | 5 |
positive test | 5 |
total rna | 5 |
repeated measures | 5 |
slightly increased | 5 |
cat every | 5 |
biochemical abnormalities | 5 |
providing educational | 5 |
considered negative | 5 |
healthy control | 5 |
detect coronaviruses | 5 |
sequence data | 5 |
histopathologically verified | 5 |
blood sampling | 5 |
macrophages infected | 5 |
irish wolfhounds | 5 |
iu kg | 5 |
negatively correlated | 5 |
immunohistological demonstration | 5 |
hours post | 5 |
mmhg sae | 5 |
viral copy | 5 |
age range | 5 |
term use | 5 |
leukocyte protein | 5 |
clinical manifestations | 5 |
larger numbers | 5 |
fip infection | 5 |
two variants | 5 |
fip exhibited | 5 |
descriptive distribution | 5 |
cell neoplasia | 5 |
aortic stenosis | 5 |
samples stored | 5 |
iii hypersensitivity | 5 |
recombination site | 5 |
domestic short | 5 |
large cohort | 5 |
brain sections | 5 |
nonvaccinated kittens | 5 |
veterinary practitioners | 5 |
cytokine profiles | 5 |
independent evaluation | 5 |
monocyte macrophage | 5 |
five different | 5 |
amoxicillin clavulanate | 5 |
total thyroxine | 5 |
german shepherd | 5 |
clinically significant | 5 |
often associated | 5 |
hypertensive cats | 5 |
commonly affected | 5 |
peritonitis virologic | 5 |
connective tissue | 5 |
animal inoculation | 5 |
study evaluated | 5 |
symptomatic cats | 5 |
confidence intervals | 5 |
mean body | 5 |
essential nutrients | 5 |
individual variability | 5 |
potentially useful | 5 |
cell counts | 5 |
gel electrophoresis | 5 |
insulin resistance | 5 |
assay using | 5 |
culture adapted | 5 |
fip occurs | 5 |
agp concentrations | 5 |
abdominal wall | 5 |
trend toward | 5 |
cats effects | 5 |
groups showed | 5 |
susceptible cats | 5 |
ckd cats | 5 |
spectrum antibiotics | 5 |
mhv infection | 5 |
point mutations | 5 |
recurrent trichobezoars | 5 |
technical assistance | 5 |
transthoracic echocardiography | 5 |
faecal sample | 5 |
chain fatty | 5 |
fully understood | 5 |
temperature sensitive | 5 |
without clinical | 5 |
neurological disease | 5 |
prospectively enrolled | 5 |
attenuated live | 5 |
inflammatory lesions | 5 |
old cat | 5 |
systolic excursion | 5 |
histological findings | 5 |
pooled plasma | 5 |
biochemical profile | 5 |
lymphocytic cholangitis | 5 |
high level | 5 |
cord involvement | 5 |
also detected | 5 |
often accompanied | 5 |
intermediate hosts | 5 |
also demonstrated | 5 |
cats clinical | 5 |
zinc sulfate | 5 |
vena cava | 5 |
week compared | 5 |
day precision | 5 |
fcov strain | 5 |
pretreatment ica | 5 |
one organ | 5 |
survival rates | 5 |
lysis buffer | 5 |
veterinary pathology | 5 |
molecular methods | 5 |
specific diagnosis | 5 |
usually present | 5 |
using kruskal | 5 |
low concentrations | 5 |
study demonstrates | 5 |
tissue biopsy | 5 |
least days | 5 |
esophageal perforation | 5 |
clinical study | 5 |
relative expression | 5 |
neutrophilic pleocytosis | 5 |
apparently healthy | 5 |
american college | 5 |
found online | 5 |
maternal antibodies | 5 |
highly plasma | 5 |
approximately ml | 5 |
kg every | 5 |
cats might | 5 |
fractional shortening | 5 |
diagnostic performance | 5 |
genetic factors | 5 |
host genetic | 5 |
every second | 5 |
positive sample | 5 |
cell apoptosis | 5 |
ag alb | 5 |
intestinal inflammatory | 5 |
highest rate | 5 |
acute toxoplasmosis | 5 |
inflammatory changes | 5 |
new strains | 5 |
monoclonal anti | 5 |
serum anti | 5 |
helicobacter spp | 5 |
spinal injury | 5 |
corresponding serum | 5 |
gastrointestinal diseases | 5 |
incubation period | 5 |
ocular disease | 5 |
serum amyloid | 5 |
controlled studies | 5 |
contrast radiographs | 5 |
cat shelter | 5 |
compatible clinical | 5 |
esophageal transit | 5 |
echocardiographic evaluation | 5 |
cats aged | 5 |
drug used | 5 |
low amounts | 5 |
young kittens | 5 |
pulmonic valve | 5 |
cardiac involvement | 5 |
medium containing | 5 |
dietary management | 5 |
overall survival | 5 |
specific primers | 5 |
showed signs | 5 |
clinical studies | 5 |
disease characterized | 5 |
significant associations | 5 |
pcr system | 5 |
horizontal transmission | 5 |
acute diarrhea | 5 |
factors include | 5 |
may appear | 5 |
mrna pcr | 5 |
intravenous administration | 5 |
virus der | 5 |
granulocyte colony | 5 |
electrolyte imbalances | 5 |
biliary tract | 5 |
variables studied | 5 |
helicobacter pylori | 5 |
results consistent | 5 |
using primers | 5 |
italia srl | 5 |
mitral regurgitation | 5 |
abdominal ultrasonography | 5 |
chronically infected | 5 |
dietary fiber | 5 |
coronavirus strains | 5 |
subtotal colectomy | 5 |
two biotypes | 4 |
feline spinal | 4 |
electrophoretic fraction | 4 |
virus alone | 4 |
fresh blood | 4 |
ml penicillin | 4 |
chronic nasal | 4 |
anemic cat | 4 |
bartonella henselae | 4 |
cardiac group | 4 |
neoplastic conditions | 4 |
virus quantity | 4 |
obstructing feces | 4 |
cytoplasmic fluorescence | 4 |
serological tests | 4 |
often seen | 4 |
studies used | 4 |
another cat | 4 |
effusive forms | 4 |
potential risk | 4 |
may relate | 4 |
feline advisory | 4 |
study described | 4 |
operator variability | 4 |
dogs undergoing | 4 |
data suggests | 4 |
sequencing primer | 4 |
open access | 4 |
feline tissues | 4 |
med surg | 4 |
study documents | 4 |
tricuspid regurgitant | 4 |
immunoperoxidase techniques | 4 |
ultrasound examination | 4 |
nasal aspergillosis | 4 |
ii non | 4 |
rv strain | 4 |
french beauce | 4 |
year study | 4 |
subgenomic mrna | 4 |
increased number | 4 |
cardiac long | 4 |
effusion serum | 4 |
coronavirus antigenic | 4 |
correlation coefficients | 4 |
cases may | 4 |
days prior | 4 |
staffordshire terrier | 4 |
microwave pretreatment | 4 |
developed non | 4 |
findings obtained | 4 |
canine patients | 4 |
referral centers | 4 |
cytoplasmic staining | 4 |
comparative group | 4 |
curve analysis | 4 |
cats less | 4 |
cell proliferation | 4 |
feline interleukin | 4 |
peritonitis infecciosa | 4 |
control animals | 4 |
also likely | 4 |
thoracic high | 4 |
ii tm | 4 |
cat tested | 4 |
adequate hydration | 4 |
monitoring system | 4 |
also supported | 4 |
intestinal tropism | 4 |